{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T20:02:00Z","timestamp":1781726520331,"version":"3.54.5"},"reference-count":66,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background: Varicella infections follow a benign course in around 90% of cases, with more severe forms occurring in adults. To identify potential pockets of susceptibility and to improve targeted immunization strategies, this study aims to critically assess immunological status by evaluating varicella seroprevalence among adults (18\u201399 years) in the province of Florence (Italy), nearly a decade after Tuscany introduced the vaccination program. Methods: A convenience sample of 430 subjects aged 18 to 94 years (mean age 51.8 \u00b1 18.8 years), stratified by age and sex (53.7% of subjects were female; N = 231), was collected between 2018 and 2019. Sero-analytical analyses were conducted utilizing EUROIMMUN Anti-VZV ELISA (IgG) kits. Results: Most of them were of Italian nationality (87.4%; N = 376). Among the 430 tested samples, 385 (89.5%) were positive and 39 (9.1%) were negative. The remaining six sera (1.4%), confirmed as equivocal, were excluded from further analysis. No significant differences were found based on sex (p-value = 0.706) or nationality (p-value = 0.112). The application of trend tests (Mantel\u2013Haenszel; Kendall Tau-b) showed a significant trend (p &lt; 0.024 and p &lt; 0.032, respectively), with an increasing probability of finding a positive anti-varicella serological status passing from a lower age group (84.2%) to a higher one (93.0%). By considering the female population aged 18\u201349 years, the seroprevalence of anti-varicella antibodies was found to be 88.4%, with a susceptibility of 11.6%, highlighting the risk of acquiring infection during pregnancy. Conclusions: The introduction of varicella vaccination has had a significant impact on public health in Tuscany and in Italy more generally. However, further efforts should be made to reduce the number of individuals still susceptible in adulthood, with particular attention given to women of childbearing age and the promotion of vaccination through mass and social media and institutional websites.<\/jats:p>","DOI":"10.3390\/vaccines12091056","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T07:36:00Z","timestamp":1726472160000},"page":"1056","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Seroprevalence Assessment of Anti-Varicella Antibodies among Adults in the Province of Florence (Italy)"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6013-8779","authenticated-orcid":false,"given":"Angela","family":"Bechini","sequence":"first","affiliation":[{"name":"Department of Health Sciences, University of Florence, 50134 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2742-0297","authenticated-orcid":false,"given":"Marco","family":"Del Riccio","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Florence, 50134 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7652-3487","authenticated-orcid":false,"given":"Cristina","family":"Salvati","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Florence, 50134 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Bonito","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Florence, 50134 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6718-1932","authenticated-orcid":false,"given":"Beatrice","family":"Zanella","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Florence, 50134 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano Alberto","family":"Biamonte","sequence":"additional","affiliation":[{"name":"Medical School of Specialization in Hygiene and Preventive Medicine, University of Florence, 50134 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9861-8891","authenticated-orcid":false,"given":"Mario","family":"Bruschi","sequence":"additional","affiliation":[{"name":"Medical School of Specialization in Hygiene and Preventive Medicine, University of Florence, 50134 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna Alexandra","family":"Iamarino","sequence":"additional","affiliation":[{"name":"Medical School of Specialization in Hygiene and Preventive Medicine, University of Florence, 50134 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5441-2460","authenticated-orcid":false,"given":"Letizia","family":"Fattorini","sequence":"additional","affiliation":[{"name":"Medical School of Specialization in Hygiene and Preventive Medicine, University of Florence, 50134 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Baggiani","sequence":"additional","affiliation":[{"name":"Azienda USL Toscana Centro, 50122 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Della Fonte","sequence":"additional","affiliation":[{"name":"Azienda USL Toscana Centro, 50122 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Mereu","sequence":"additional","affiliation":[{"name":"Azienda USL Toscana Centro, 50122 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2875-3744","authenticated-orcid":false,"given":"Paolo","family":"Bonanni","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Florence, 50134 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Working","family":"Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9695-7549","authenticated-orcid":false,"given":"Sara","family":"Boccalini","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Florence, 50134 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,16]]},"reference":[{"key":"ref_1","first-page":"95","article-title":"Varicella-zoster virus infection: Natural history, clinical manifestations, immunity and current and future vaccination strategies","volume":"41","author":"Freer","year":"2018","journal-title":"New Microbiol."},{"key":"ref_2","unstructured":"Orenstein, W.A., Offit, P.A., Edwards, K.M., and Plotkin, S.A. (2018). Varicella vaccine. Vaccines, Elsevier. [7th ed.]."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Bonanni, P., Breuer, J., Gershon, A., Gershon, M., Hryniewicz, W., Papaevangelou, V., Rentier, B., R\u00fcmke, H., Sadzot-Delvaux, C., and Senterre, J. (2009). Varicella vaccination in Europ\u2014Taking the practical approach. BMC Med., 7.","DOI":"10.1186\/1741-7015-7-26"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/S0140-6736(94)92943-2","article-title":"Consequences of varicella and herpes zoster in pregnancy: Prospective study of 1739 cases","volume":"343","author":"Enders","year":"1994","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/infdis\/172.3.706","article-title":"The epidemiology of varicella and its complications","volume":"172","author":"Choo","year":"1995","journal-title":"J. Infect. Dis."},{"key":"ref_6","unstructured":"CDC Prevention of Varicella (2024, March 18). ACIP, Available online: https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr5604a1.htm."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s40121-023-00899-7","article-title":"Global Prevalence of Varicella-Associated Complications: A Systematic Review and Meta-Analysis","volume":"13","author":"Shah","year":"2024","journal-title":"Infect. Dis. Ther."},{"key":"ref_8","unstructured":"World Health Organization (2024, March 18). Varicella and Herpes Zoster Vaccines: WHO Position Paper. Available online: https:\/\/www.who.int\/publications\/i\/item\/who-wer-8925-265-288."},{"key":"ref_9","unstructured":"European Centre for Disease Prevention and Control (2024, March 30). Varicella Report. Available online: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/varicella-surveillance-report-2010."},{"key":"ref_10","unstructured":"Istituto Superiore di Sanit\u00e0 (2024, March 18). Varicella. EpiCentro., Available online: https:\/\/www.epicentro.iss.it\/varicella\/."},{"key":"ref_11","first-page":"213","article-title":"Varicella-zoster virus: Pathogenesis, incidence patterns and vaccination programs","volume":"68","author":"Gabutti","year":"2016","journal-title":"Minerva Pediatr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/INF.0b013e31829ae263","article-title":"The effectiveness of varicella vaccination in children in Germany: A case-control study","volume":"32","author":"Liese","year":"2013","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1016\/j.vaccine.2017.05.013","article-title":"Impact and effectiveness of childhood varicella vaccine program in Queensland, Australia","volume":"35","author":"Sheridan","year":"2017","journal-title":"Vaccine"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"5665","DOI":"10.1016\/j.vaccine.2018.05.025","article-title":"Varicella breakthrough infection and effectiveness of 2-dose varicella vaccine in China","volume":"36","author":"Pan","year":"2018","journal-title":"Vaccine"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"S375","DOI":"10.1093\/infdis\/jiac251","article-title":"25 Years of Varicella Vaccination in the United States","volume":"226","author":"Marin","year":"2022","journal-title":"J. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1086\/522145","article-title":"Varicella vaccine effectiveness in the US vaccination program: A review","volume":"197","author":"Seward","year":"2008","journal-title":"J. Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e1389","DOI":"10.1542\/peds.2012-3303","article-title":"Long-term effectiveness of varicella vaccine: A 14-Year, prospective cohort study","volume":"131","author":"Baxter","year":"2013","journal-title":"Pediatrics"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.4161\/hv.23451","article-title":"Effectiveness of one and two doses of varicella vaccine in preventing laboratory-confirmed cases in children in Navarre, Spain","volume":"9","author":"Cenoz","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_19","first-page":"E120","article-title":"Impact of vaccination programs against measles, varicella and meningococcus C in Italy and in Tuscany and public health policies in the last decades","volume":"59","author":"Bechini","year":"2018","journal-title":"J. Prev. Med. Hyg."},{"key":"ref_20","unstructured":"Tuscany Region (2024, August 07). [Direttive Regionali in Materia di Vaccinazioni]. Available online: https:\/\/www.regione.toscana.it\/documents\/10180\/23315\/Direttive%20regionali%20su%20vaccinazioni\/426dc728-5218-4a49-a842-9b724dfb8d7e."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Zanella, B., Boccalini, S., Bonito, B., Del Riccio, M., Manzi, F., Tiscione, E., Bonanni, P., Working Group DHS, Working Group AOUMeyer, and Working Group AUSLTC (2020). Rubella Seroprevalence Boost in the Pediatric and Adolescent Population of Florence (Italy) as a Preventive Strategy for Congenital Rubella Syndrome (CRS). Vaccines, 8.","DOI":"10.3390\/vaccines8040599"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Zanella, B., Bechini, A., Boccalini, S., Sartor, G., Tiscione, E., Working Group AOUMeyer, Working Group AUSLTC, and Bonanni, P. (2020). Hepatitis B Seroprevalence in the Pediatric and Adolescent Population of Florence (Italy): An Update 27 Years after the Implementation of Universal Vaccination. Vaccines, 8.","DOI":"10.3390\/vaccines8020156"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Zanella, B., Boccalini, S., Bonito, B., Del Riccio, M., Tiscione, E., Bonanni, P., Working Group DHS, Working Group AOUMeyer, Working Group AUSLTC, and Bechini, A. (2020). Increasing Measles Seroprevalence in a Sample of Pediatric and Adolescent Population of Tuscany (Italy): A Vaccination Campaign Success. Vaccines, 8.","DOI":"10.3390\/vaccines8030512"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Zanella, B., Boccalini, S., Biamonte, M.A., Giorgetti, D., Menicacci, M., Bonito, B., Ninci, A., Tiscione, E., Puggelli, F., and Mereu, G. (2021). A Study of Hepatitis A Seroprevalence in a Paediatric and Adolescent Population of the Province of Florence (Italy) in the Period 2017-2018 Confirms Tuscany a Low Endemic Area. Vaccines, 9.","DOI":"10.3390\/vaccines9101194"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Zanella, B., Bechini, A., Bonito, B., Del Riccio, M., Ninci, A., Tiscione, E., Working Group DHS, Working Group AOUMeyer, Working Group AUSLTC, and Bonanni, P. (2021). A Study of Varicella Seroprevalence in a Pediatric and Adolescent Population in Florence (Italy). Natural Infection and Vaccination- Acquired Immunization. Vaccines, 9.","DOI":"10.3390\/vaccines9020152"},{"key":"ref_26","unstructured":"Bechini, A., Zanella, B., Bonito, B., Betti, M., Stancanelli, E., Del Riccio, M., Salvati, C., Bonanni, P., Bianchi, J., and Biondi, I. (2024). Anti-rubella seroprevalence assessment in an adult sample population in Italy. Ann. Ig., Epub ahead of print."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Gabutti, G., Grassi, T., Bagordo, F., Savio, M., Rota, M.C., Castiglia, P., Baldovin, T., Napolitano, F., Panico, A., and Ogliastro, M. (2023). Sero-Epidemiological Study of Varicella in the Italian General Population. Vaccines, 11.","DOI":"10.3390\/vaccines11020306"},{"key":"ref_28","unstructured":"ARS Toscana (2024, March 18). Rapporto ARS n.5. La Sorveglianza Epidemiologica delle Malattie Infettive in Toscana 2022. Available online: https:\/\/www.ars.toscana.it\/2-articoli\/4838-sorveglianza-epidemiologica-malattie-infettive-toscana-2021-rapporto-ars-2.html."},{"key":"ref_29","unstructured":"Ministero della Salute (2024, May 27). Vaccinazioni Dell\u2019et\u00e0 Pediatrica e Dell\u2019adolescenza-Coperture Vaccinali. Ministero della Salute, Available online: https:\/\/www.salute.gov.it\/portale\/documentazione\/p6_2_8_3_1.jsp?lingua=italiano&id=20."},{"key":"ref_30","unstructured":"Istituto Superiore di Sanit\u00e0 (2024, May 27). Piano Nazionale di Prevenzione Vaccinale (PNPV) 2017\u20132019. Available online: https:\/\/www.epicentro.iss.it\/vaccini\/piano-nazionale-vaccini-2017-2019."},{"key":"ref_31","unstructured":"Istituto Superiore di Sanit\u00e0 (2024, May 27). Piano Nazionale di Prevenzione Vaccinale (PNPV) 2023\u20132025. Available online: https:\/\/www.epicentro.iss.it\/vaccini\/piano-nazionale-vaccini-2023-2025."},{"key":"ref_32","unstructured":"Ministero della Salute (2024, August 02). Conversione in Legge, con Modificazioni, del Decreto-Legge 7 Giugno 2017, n. 73, Recante Disposizioni Urgenti in Materia di Prevenzione Vaccinale. (17G00132). Legge 31 Luglio 2017, n. 119. G.U. Serie Generale, n. 182 del 05 Agosto 2017 [Internet], Available online: https:\/\/www.trovanorme.salute.gov.it\/norme\/dettaglioAtto?id=60201."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/INF.0000000000002233","article-title":"Implementing Universal Varicella Vaccination in Europe: The Path Forward","volume":"38","author":"Spoulou","year":"2019","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0264-410X(00)00178-X","article-title":"Seroepidemiology of varicella-zoster virus infection in Catalonia (Spain). Rationale for universal vaccination programmes","volume":"19","author":"Salleras","year":"2000","journal-title":"Vaccine"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"6535","DOI":"10.1016\/j.vaccine.2023.09.024","article-title":"Decline in varicella cases contacting primary health care after introduction of varicella vaccination in Finland-A population-based register study","volume":"41","author":"Salo","year":"2023","journal-title":"Vaccine"},{"key":"ref_36","unstructured":"Epicentro (2024, May 27). Istituto Superiore di Sanit\u00e0. Vaccini e Vaccinazioni. Coperture Vaccinali in Italia. Available online: https:\/\/www.epicentro.iss.it\/vaccini\/."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Perfetto, B., Paduano, G., Grimaldi, E., Sansone, V., Donnarumma, G., and Di Giuseppe, G. (2024). Seroprevalence for Measles, Varicella, Mumps and Rubella in the Trainee Obstetric Population: A Survey in Southern Italy. Vaccines, 12.","DOI":"10.3390\/vaccines12030335"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.vaccine.2024.01.038","article-title":"Vaccine-preventable diseases: Immune response in a large population of healthcare students","volume":"42","author":"Santoro","year":"2024","journal-title":"Vaccine"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"taae004","DOI":"10.1093\/jtm\/taae004","article-title":"Measles, mumps, rubella and varicella antibodies among international and domestic university students","volume":"31","author":"Dyda","year":"2024","journal-title":"J. Travel Med."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Frau, N., Meloni, F., Fostinelli, J., Portas, L., Portoghese, I., Sala, E., Pilia, I., Lecca, L.I., De Palma, G., and Campagna, M. (2021). Seroepidemiology of Measles, Mumps, Rubella and Varicella in Italian Female School Workers: A Cross-Sectional Study. Vaccines, 9.","DOI":"10.3390\/vaccines9101191"},{"key":"ref_41","first-page":"525","article-title":"Seroprevalence of measles, mumps, rubella, and varicella zoster virus antibodies among healthcare students: Analysis of vaccine efficacy and cost-effectiveness","volume":"32","author":"Akbulut","year":"2019","journal-title":"Rev. Esp. Quimioter"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jmii.2022.09.005","article-title":"Seroprevalence of varicella-zoster virus antibody and immunogenicity of live attenuated varicella vaccine in healthcare workers in Taiwan","volume":"56","author":"Chong","year":"2023","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jiph.2020.01.309","article-title":"Seroepidemiology of hepatitis viruses, measles, mumps, rubella and varicella among healthcare workers and students: Should we screen before vaccination?","volume":"13","author":"Karadeniz","year":"2020","journal-title":"J. Infect. Public Health"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"358","DOI":"10.5455\/medarh.2023.77.358-362","article-title":"Seroprevalence of Varicella Zoster Virus in the Eastern Province of Saudi Arabia in Post-vaccination Era","volume":"77","year":"2023","journal-title":"Med. Arch."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"6544","DOI":"10.1016\/j.vaccine.2014.08.088","article-title":"A seroprevalence survey on varicella among adults in the vaccination era in Apulia (Italy)","volume":"32","author":"Tafuri","year":"2014","journal-title":"Vaccine"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Bianchi, F.P., Tafuri, S., Larocca, A.M.V., Germinario, C.A., and Stefanizzi, P. (2021). Long -term persistence of antibodies against varicella in fully immunized healthcare workers: An Italian retrospective cohort study. BMC Infect. Dis., 21.","DOI":"10.1186\/s12879-021-06180-x"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Mirinaviciute, G., Barlinn, R., Gjeruldsen Dudman, S., and Flem, E. (2019). Immunity to varicella zoster virus among pregnant women in the Norwegian Mother and Child Cohort Study. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0221084"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4103\/ijpvm.ijpvm_239_22","article-title":"Seroprevalence of VZV and HSV-2 Antibodies among Women of Childbearing Age Referring to Health Centres of Mashhad, Iran: The Need for Consideration of VZV Vaccination Program","volume":"14","author":"Youssefi","year":"2023","journal-title":"Int. J. Prev. Med."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Chughtai, A.A., He, W.Q., and Liu, B. (2023). Associations between severe and notifiable respiratory infections during the first trimester of pregnancy and congenital anomalies at birth: A register-based cohort study. BMC Pregnancy Childbirth, 23.","DOI":"10.1186\/s12884-023-05514-8"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"278","DOI":"10.5005\/jp-journals-11002-0040","article-title":"Congenital and Perinatal Varicella Infections","volume":"1","author":"Singh","year":"2022","journal-title":"Newborn"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Trombetta, C.M., Montomoli, E., Viviani, S., Coluccio, R., and Marchi, S. (2020). Evaluation of Varicella Immunity during Pregnancy in Apulia Region, Southern Italy. Vaccines, 8.","DOI":"10.3390\/vaccines8020214"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s10096-018-3286-7","article-title":"Management of chickenpox in pregnant women: An Italian perspective","volume":"37","author":"Parente","year":"2018","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1017\/S0950268802006878","article-title":"Assessment of varicella underreporting in Italy","volume":"128","author":"Rota","year":"2002","journal-title":"Epidemiol. Infect."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"S400","DOI":"10.1093\/infdis\/jiac214","article-title":"Changing Epidemiology of Varicella Outbreaks in the United States During the Varicella Vaccination Program, 1995\u20132019","volume":"226","author":"Leung","year":"2022","journal-title":"J. Infect. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.46234\/ccdcw2023.218","article-title":"Epidemiological Characteristics of Varicella Outbreaks-China, 2006\u20132022","volume":"5","author":"Wang","year":"2023","journal-title":"China CDC Wkly."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1086\/522144","article-title":"Varicella outbreak epidemiology in an active surveillance site, 1995\u20132005","volume":"197","author":"Civen","year":"2008","journal-title":"J. Infect. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"S450","DOI":"10.1093\/infdis\/jiac363","article-title":"Diagnostic and Immunologic Testing for Varicella in the Era of High-Impact Varicella Vaccination: An Evolving Problem","volume":"226","author":"Dollard","year":"2022","journal-title":"J. Infect. Dis."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"S380","DOI":"10.1093\/infdis\/jiac390","article-title":"Clinical Manifestations of Varicella: Disease Is Largely Forgotten, but It\u2019s Not Gone","volume":"226","author":"Dooling","year":"2022","journal-title":"J. Infect. Dis."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Boccalini, S., Bonanni, P., Chiesi, F., Di Pisa, G., Furlan, F., Giammarco, B., Zanella, B., Mand\u00f2 Tacconi, F., and Bechini, A. (2020). The Experience of VaccinarSinToscana Website and the Role of New Media in Promoting Vaccination. Vaccines, 8.","DOI":"10.3390\/vaccines8040644"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Arghittu, A., Dettori, M., Dempsey, E., Deiana, G., Angelini, C., Bechini, A., Bertoni, C., Boccalini, S., Bonanni, P., and Cinquetti, S. (2021). Health Communication in COVID-19 Era: Experiences from the Italian VaccinarS\u00ec Network Websites. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18115642"},{"key":"ref_61","first-page":"109","article-title":"Six years of activity of the Italian vaccine portal \u201cVaccinarS\u00ec\u201d: A web traffic evaluation using Google Analytics","volume":"33","author":"Bordin","year":"2021","journal-title":"Ann. Ig."},{"key":"ref_62","first-page":"88","article-title":"Monitoring the web to support vaccine coverage: Results of two years of the portal VaccinarS\u00ec","volume":"39","author":"Ferro","year":"2015","journal-title":"Epidemiol. Prev."},{"key":"ref_63","unstructured":"Arghittu, A., Deiana, G., Dettori, M., Dempsey, E., Masia, M.D., Plamieri, A., Spano, A.L., Azara, A., and Castiglia, P. (2021). Web-based analysis on the role of Digital Media in Health Communication: The experience of VaccinarSinSardegna Website. Acta Biomed., 92."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vaccine.2023.11.060","article-title":"The Adult Immunization Board (AIB): A new platform to provide multidisciplinary guidelines for the implementation and optimization of adult immunization in Europe","volume":"42","author":"Pattyn","year":"2024","journal-title":"Vaccine"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Antonelli-Incalzi, R., Blasi, F., Conversano, M., Gabutti, G., Giuffrida, S., Maggi, S., Marano, C., Rossi, A., and Vicentini, M. (2021). Manifesto on the Value of Adult Immunization: \u201cWe Know, We Intend, We Advocate\u201d. Vaccines, 9.","DOI":"10.3390\/vaccines9111232"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/07853890.2017.1417632","article-title":"Challenges in adult vaccination","volume":"50","author":"Doherty","year":"2018","journal-title":"Ann. Med."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/9\/1056\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:57:24Z","timestamp":1760111844000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/9\/1056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,16]]},"references-count":66,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["vaccines12091056"],"URL":"https:\/\/doi.org\/10.3390\/vaccines12091056","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,16]]}}}